Showing 35,658 results

Side effects

Side-effects of HIV treatment

About HIV
June 2025
Treatment interruptions

HIV treatment breaks

About HIV
June 2025
Experiences of stigma

Your own feelings about having HIV

About HIV
June 2025
Experiences of stigma

What are HIV stigma and discrimination?

About HIV
June 2025
Smoking

Smoking and HIV

About HIV
June 2025
Chemsex & recreational drug use

Interactions between HIV medication and recreational drugs

About HIV
June 2025
Treatment guidelines

Federal HIV Guidelines Face a Shutdown — A Critical Loss for Clinicians and Patients

Editor's pick
HIV and ID Observations
24 June 2025
Injectable & long-acting PrEP

Will long-lasting HIV preventive be a game changer—or a missed opportunity?

Editor's pick
Science Magazine
24 June 2025
Vaginal rings & topical PrEP

HIV Prevention Vaginal Ring Recommended for 16-Year-Olds

Editor's pick
Medscape (requires free registration)
24 June 2025
The search for a cure

Could Lipid Nanoparticles and mRNA Truly Be Our Path to an HIV Cure?

Editor's pick
TheBodyPro
24 June 2025
Cancer

Research Sheds Light on Lung Cancer Among People Living With HIV

Editor's pick
MedPage Today
24 June 2025
Health services & systems

Village Apothecary Continues to Go Above and Beyond

Editor's pick
POZ
24 June 2025
Cardiovascular disease

Cholesterol and HIV

About HIV
June 2025
Health problems & ageing

Diarrhoea and HIV

About HIV
June 2025
HIV treatment

The stages of HIV infection

About HIV
June 2025
Cancer

Are Cancer Rates Declining Among People With HIV?

Editor's pick
POZ
19 June 2025
Global health initiatives

Will UNAIDS sunset by 2030?

Editor's pick
Devex (requires free registration)
19 June 2025
Injectable & long-acting PrEP

HIV protection with just two shots a year: FDA approves Gilead drug

Editor's pick
STAT
19 June 2025
Injectable & long-acting PrEP

Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection

Editor's pick
Gilead Sciences press release
19 June 2025
Pharmaceutical industry

FDA approves twice-yearly shot of Gilead drug for HIV prevention

Editor's pick
BioPharma Dive
19 June 2025
Behaviour change interventions

Using AI to find persuasive HIV public health messages and automate real-time campaigns

Editor's pick
Medical Xpress
18 June 2025
Exposure to HIV through medical procedures

Ban on gay and bisexual men donating blood and plasma in Australia to be scrapped

Editor's pick
The Guardian
18 June 2025
Injectable & long-acting PrEP

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Editor's pick
The Guardian
17 June 2025
Injectable & long-acting HIV treatment

Long-acting injectable HIV treatment highly effective in people with a detectable viral load and adherence challenges

Editor's pick
CATIE
17 June 2025